Search results for " therapeutic" in Articles / App Notes

Article USP Publishes Monoclonal Antibody Guidelines
USP standards for mAbs Currently, licensed monoclonal antibody (mAb) therapeutics include those involved in the activation of effector cells, cell killing, cross-linked induced apoptosis, antagonis…

Article Ligand-Binding Assays and the Determination of Biosimilarity
Ligand-binding assays are of great importance for the analysis and comparison of the originator and biosimilar therapeutic for both testing of the drug before administration to preclinical or clinical…

Article Monoclonal Antibodies Key to Unlocking the Biosimilars Market
However, countless patients around the world do not have access to these state-of-the-art therapeutics due to their high price. Celltrion’s goal is to make antibodies more affordable to patients throu…

Article Evaluating the Use of Continuous Chromatography
In downstream processing, continuous chromatography is gaining traction in the purification of protein therapeutics. As the biopharmaceutical industry strives to demonstrate, continuous manufacturing …

Article Exosome isolation by tangential flow filtration and size exclusion chromatography
Acknowledgements to VivaZome Therapeutics Pty Ltd and Evox Therapeutics Ltd for contributions to this application note. READ THE FULL APPLICATION NOTE

Article The oligonucleotide synthesis process consists of a repetitive four-step cycle
The oligo therapeutics market is growing in promise for treating cancers, genetic diseases, and other conditions. In this animated video you can watch the oligonucleotide synthesis process as …

Article Oligonucleotide manufacturing: how to get a strong start
Oligonucleotide therapeutics have huge potential for transforming human health. If you’re a small biotech or lab developing such therapies, playing the long game is crucial to successful in-ho…

Article Get a strong start in oligonucleotide manufacturing
Oligonucleotide therapeutics hold incredible promise. How can you harness their full potential? When starting process development, you need to know where to focus, and you need a scalable a…

Article Process Development challenges for mRNA vaccines and beyond
Key insights from industry experts on the future of therapeutic mRNA manufacturing. READ MORE >>

Article Enhancing Resins Addresses Purification Concerns
“These empty capsids do not contain the therapeutic gene of interest and can elicit an undesirable patient immune response (4). Therefore, removal of these empty capsid particles is critical during th…

Show All Results

Previous PageNext Page